PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+16.95%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.93B
AUM Growth
+$180M
(+10%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
5.85%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
191
New
20
Increased
30
Reduced
38
Closed
64
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$64.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$58.2M |
| 3 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$38M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$23.8M |
| 5 |
Intuitive Surgical
ISRG
|
$19.4M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$37.6M |
| 2 |
Sarepta Therapeutics
SRPT
|
$23M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$20.4M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14.6M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.6M |
Sector Composition
| 1 | Healthcare | 96.53% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Energy | 0.04% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
26
DELISTED
Acceleron Pharma Inc.
XLRN
| $21.6M | 1.09% |
711,259
+47,402
| +7% | +$1.44M |
|
27
CytomX Therapeutics
CTMX
$346M
| $21.6M | 1.08% |
1,390,381
-140,278
| -9% | -$2.17M |
|
|
DBVT
28
DBV Technologies
DBVT
$252M
| $21.1M | 1.06% |
59,177
| – | – |
|
|
KDMN
29
DELISTED
Kadmon Holdings, Inc.
KDMN
| $20.2M | 1.02% |
5,185,847
| – | – |
|
|
30
Intuitive Surgical
ISRG
$163B
| $19.4M | 0.97% |
+186,255
| New | +$19.4M |
|
31
Humana
HUM
$37.5B
| $18.8M | 0.95% |
78,093
+50,593
| +184% | +$12.2M |
|
|
ALBO
32
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $17.4M | 0.88% |
+845,000
| New | +$17.4M |
|
33
Galapagos
GLPG
$2.1B
| $17.3M | 0.87% |
226,405
-45,000
| -17% | -$3.44M |
|
34
Cartesian Therapeutics
RNAC
$260M
| $15.8M | 0.8% |
26,578
+21,849
| +462% | +$13M |
|
35
Akebia Therapeutics
AKBA
$801M
| $15.8M | 0.8% |
1,100,000
+1,050,376
| +2,117% | +$15.1M |
|
|
AVDL
36
Avadel Pharmaceuticals
AVDL
$1.46B
| $15.8M | 0.79% |
1,429,114
+20,874
| +1% | +$230K |
|
|
MYOK
37
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.5M | 0.73% |
553,154
-71,540
| -11% | -$1.87M |
|
|
ATRS
38
DELISTED
Antares Pharma, Inc.
ATRS
| $13.7M | 0.69% |
4,267,253
+1,350,000
| +46% | +$4.35M |
|
|
BOLD
39
DELISTED
Audentes Therapeutics, Inc
BOLD
| $13.5M | 0.68% |
707,500
+700,000
| +9,333% | +$13.4M |
|
40
Aldeyra Therapeutics
ALDX
$332M
| $13.4M | 0.68% |
2,885,458
| – | – |
|
|
AVEO
41
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $13.3M | 0.67% |
601,066
+90,185
| +18% | +$2M |
|
42
Jazz Pharmaceuticals
JAZZ
$7.77B
| $13.3M | 0.67% |
85,572
+55,572
| +185% | +$8.64M |
|
|
SIOX
43
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $13.3M | 0.67% |
71,588
+32,838
| +85% | +$6.09M |
|
44
Wave Life Sciences
WVE
$1.3B
| $12.3M | 0.62% |
662,798
-2,400
| -0.4% | -$44.6K |
|
45
iRhythm Technologies
IRTC
$5.85B
| $12M | 0.6% |
282,857
+11,800
| +4% | +$501K |
|
46
argenx
ARGX
$44.9B
| $9.54M | 0.48% |
+450,000
| New | +$9.54M |
|
47
Ardelyx
ARDX
$1.58B
| $9.23M | 0.46% |
1,810,581
-75,615
| -4% | -$386K |
|
48
Assembly Biosciences
ASMB
$179M
| $9.12M | 0.46% |
36,819
-18,544
| -33% | -$4.6M |
|
49
Sonida Senior Living
SNDA
$486M
| $8.06M | 0.41% |
35,345
-3,000
| -8% | -$684K |
|
50
Talphera
TLPH
$10.6M
| $8.02M | 0.4% |
186,567
-83,869
| -31% | -$3.61M |
|